Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Analysis of 109 well documented cases of permanent total atrial paralysis reported in the literature illustrated the features of this arrhythmia which is a well defined entity consisting of suppression of all electrical and mechanical activity of both atria lasting for more than 6 months. Standard electrocardiogram reveals junctional bradycardia of about 40 bpm without any visible P waves and narrow supraventricular QRS complexes in 80% of cases. This diagnosis can only be confirmed by meticulous bipolar endocavitary recordings exploring all atrial walls without recording an auriculogram and by right intra-atrial and coronary sinus stimulation which proves to be ineffective. This disease has a male predominance in two-thirds of cases and a familial nature in 18% of cases. Seventy one per cent of affected subjects are under the age of 50 years. In 33% of cases, it is associated with Emery-Dreifuss muscular dystrophy, in which it constitutes a specific sign allowing this dystrophy to be differentiated from all other forms, especially facio-scapulo-humeral myopathy, and in 30% of cases, it is associated with a degenerative disease such as
diabetes
,
amyloidosis
or primary cardiomyopathy. Idiopathic dilatation of the right atrium is revealed in 15% of cases. The arrhythmia is responsible for syncope or faintness in 31% of cases, cerebral vascular accidents in 21% of cases and heart failure in 35% of cases. Cardiac activation is dependent on a junctional escape rhythm. The mechanism of the lesion responsible is atrial fibrosis which may extend to the sinoatrial node. The treatment of choice consists of implantation of a VVI or VVIR mode cardiac pacemaker in combination with anticoagulant therapy.
...
PMID:[Total permanent auricular paralysis. Review of the literature apropos of 109 cases]. 779 52
In the randomized autopsy material of 161 patients with rheumatoid arthritis (RA), a letal, generalized septic infection (GSI) was observed in 22 cases (13.66%). The GSI was accompanied by a pyarthros in 12 (7.45%) and no pyarthros in 10 (6.21%) cases. The clinical parameters of 22 septic RA patients were compared with 139 age and sex matched RA patients without GSI. The average age of septic patients decreased (p < 0.02), with low serum electrophoretic b-globulin level (p < 0.04), and high Waaler-Rose (p < 0.02) and Latex level (p < 0.004). The clinical parameters of 22 septic patients were compared with 76 age and sex matched RA patients without sepsis, vasculitis, or generalized secondary
amyloidosis
(GSA), and/or miliary epitheloid granulomas of tuberculous type (mT). The differences between the two groups of patients were the same, with a statistically more pronounced age difference (p < 0.005). 29 out of 161 patients (18.01 %) suffered from a clinically manifest
diabetes mellitus
(in 6 patients accompanied by sepsis), and 11 (6.83 %) from a clinically latent
diabetes mellitus
(in 2 patients accompanied by sepsis). There was no significant relationship between sepsis and manifest
diabetes mellitus
. The controlled and treated
diabetes mellitus
does not influence the frequency of lethal sepsis. Significant correlations were found between sepsis and latent
diabetes mellitus
(based on the histological detection of amyloid deposition localized to the islets of Langerhans (p < 0.02). 34 out of 161 patients (21.12%) suffered from a generalized secondary
amyloidosis
(in 3 patients accompanied by sepsis). There was no significant relationship between sepsis and generalized secondary
amyloidosis
. The thickness of adrenal cortex represents the effect of steroid therapy. Critical random check, using the Mann-Whitney tests, supports significance relationship between the adrenal cortex atrophy and fatal sepsis (p < 0.010). The follicular lymphoid depletion in the spleen represents the effect of immunosuppressive therapy. The size of lympho-follicles decreased significantly in sepsis (p < 0.004). The long term corticosteroid therapy and immunosuppressive represent a potential danger for sepsis.
...
PMID:[Generalized septic infections in rheumatoid arthritis. Study of autopsy material]. 782 86
A prominent feature in several diseases is the accumulation of connective tissue. The ultimate result of high levels of extracellular matrix is organ failure and death, evident in diseases such as liver fibrosis,
diabetes
and
amyloidosis
. Among the extracellular matrix components, proteoglycans play a basic role in several pathological conditions. In the development of atherosclerosis they provide an anchor for lipoprotein lipase on the endothelial wall, sequester lipoproteins in the subendothelial matrix and present lipoproteins to macrophages. In
diabetes
these proteoglycans have a lower charge, such that the network has a reduced capacity to retain negatively charged proteins. In fibrosis and
amyloidosis
the synthesis of proteoglycans and matrix is increased and large amounts are deposited at the expense of tissue-specific cells. Some of the conditions mentioned can be ameliorated by changes in the diet.
...
PMID:[The significance of proteoglycans in several diseases]. 799 94
We report islet hyperplasia, nesidioblastosis, and abundant islet
amyloidosis
(derived from islet amyloid polypeptide) in a case of severe insulin resistance due to a circulating antiinsulin receptor antibody. Massive chronic beta-cell stimulation (as well as noninsulin-dependent
diabetes mellitus
and insulinoma) appears to be associated with islet amyloid.
...
PMID:Islet amyloidosis in a patient with chronic massive insulin resistance due to antiinsulin receptor antibodies. 802 43
Significant advances were made this year in the understanding of serum amyloid A isotypes and in the definition of different amyloid light-chain proteins. Increasing numbers of hereditary amyloid-related transthyretin mutations have been reported (more than 30 to date). Two new hereditary amyloid proteins in several different kinships have appeared, ie, fibrinogen A alpha and lysozyme, each with a single point mutation. Both were found in patients with non-neurogenic hereditary
amyloidosis
with severe nephropathy. In islet amyloid polypeptide, the amyloid of adult-onset
diabetes
, the amino-acid sequence Ala-Ile-Leu-Ser at positions 25 to 28 appears to be critical for fibrillogenesis.
...
PMID:Proteins of the systemic amyloidoses. 803 80
478 eyes of 313 patients aged from 25 to 90 years and older were investigated (postmortem and surgical material was used). Patients had cataracts, glaucoma,
diabetes mellitus
. The goal of the study was establishing the amyloid nature of the pseudoexfoliative material (PEM) in the anterior part of the eye. The study showed PEM to be a variety of the amyloid-pseudoexfoliative amyloid (PEA) which was found in 66 (14%) eyes. The localisation and morphology of PEA in various parts of the eye are described in detail. PEA may be the only manifestation of the senile eye
amyloidosis
, but may be combined with insular
amyloidosis
of the pancreas.
...
PMID:[Amyloidosis of the eye combined with other senile pathology]. 812 75
One observation of isolated
amyloidosis
of the insular apparatus of the pancreas followed by the development of
diabetes mellitus
and diabetic microangiopathy in various organs is described. Total amyloid involvement of all insular apparatus is pointed out.
...
PMID:[Isolated amyloidosis of the islands of Langerhans and diabetic mellitus]. 820 60
Islet
amyloidosis
(IA) is the principal lesion in the endocrine pancreas of human beings with non-insulin-dependent
diabetes mellitus
(NIDDM) and in the similar forms of
diabetes mellitus
in domestic cats and macaques. As such, the delineation of the pathogenesis of this form of
amyloidosis
may be crucial to the understanding of the development and progression of NIDDM. Islet amyloid polypeptide (IAPP) is a recently discovered polypeptide that is the principal constituent of IA in human beings, cats, and macaques. IAPP is produced by the pancreatic beta-cells and is co-packaged with insulin in the beta-cell secretory vesicles. Immunohistochemical and physiologic evidence supports the notion that the beta-cells are heterogenous with respect to their relative contents of insulin and IAPP. Therefore, although IAPP is co-secreted with insulin in response to a variety of well-known insulin secretagogues, the molar ratio of these two proteins that is released from the islets may vary, depending upon the glucose concentration and prevailing metabolic milieu. IAPP is highly conserved among mammalian species and has about 45% homology to another neuropeptide, calcitonin gene-related peptide. IAPP is encoded by a single-copy gene located, in the human being, on chromosome 12. IAPP is expressed as a 93 (murine)-89 (human)-amino acid prepropolypeptide that is processed enzymatically, resulting in the removal of amino- and carboxy-terminal propeptide segments. The 20-29 region of the IAPP molecule is most important in the ability of IAPP to form amyloid fibrils. The role of IAPP and IA in the pathogenesis of human NIDDM and similar forms of
diabetes mellitus
in cats and macaques may involve several possible mechanisms, including 1) direct physical/chemical damage to beta-cells, resulting in necrosis and loss of functional islet tissue, 2) biologic activities of IAPP that oppose those of insulin or abnormally suppress insulin secretion, and 3) interference by IA deposits of passage of insulin out of beta-cells and/or entrance of glucose and other secretogogues into the islet. The roles of each of these possible mechanisms have yet to be demonstrated. In addition, the physiological significance of the apparent IAPP deficiency in both insulin-dependent
diabetes mellitus
and NIDDM is currently unknown.
...
PMID:Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. 821 54
Diabetes mellitus
in Macaca mulatta rhesus monkeys is preceded by phases of obesity and hyperinsulinaemia and is similar to Type 2 (non-insulin-dependent)
diabetes mellitus
in man. To relate the progression of the disease to quantitative changes in islet morphology, post-mortem pancreatic tissue from 26 monkeys was examined. Four groups of animals were studied: group I--young, lean and normal (n = 3); group II--older (> 10 years), lean and obese, normoglycaemic (n = 9); group III--normoglycaemic and hyperinsulinaemic (n = 6); group IV--diabetic (n = 8). Areas of islet amyloid, beta cells and islets were measured on stained histological sections. Islet size was larger in animals from groups III (p < 0.01) and IV (p < 0.0001) compared to groups I and II. The mean beta-cell area per islet in micron 2 was increased in group III (p < 0.05) and reduced in group IV (p < 0.001) compared to groups I and II. Mean beta-cell area per islet correlated with fasting plasma insulin (r = 0.76, p < 0.001) suggesting that hyper- and hypoinsulinaemia are related to the beta-cell population. Amyloid was absent in group I but small deposits were present in three of nine (group II) and in four of six (group III) animals, occupying between 0.03-45% of the islet space. Amyloid was present in eight of eight diabetic animals (group IV) occupying between 37-81% of the islet area. Every islet was affected in seven of eight diabetic monkeys. There was no correlation of degree of
amyloidosis
with age, body weight, body fat proportion or fasting insulin. Islet amyloid appears to precede the development of overt
diabetes
in Macaca mulatta and is likely to be a factor in the destruction of islet cells and onset of hyperglycaemia.
...
PMID:Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. 831 40
A 62-year-old woman, who had been diagnosed as having rheumatoid arthritis (RA) with systemic
amyloidosis
and
diabetes mellitus
, was admitted to our hospital because of polyarthralgia on October 1, 1987. She had some subcutaneous nodules and rheumatic pleural effusion. Therefore she was treated with 20 milligrams of prednisolone (PSL) daily. On the ninth day after the beginning of steroid therapy, she complained of severe pain and a new swelling in her right knee joint. The knee joint aspirate on arthrocentesis yielded a pure growth of group B Streptococcus (GBS). Blood culture was also positive for GBS. Her suppurative arthritis gradually improved by treatment with penicillin G. However, after the discontinuance of PSL, her pleural effusion deteriorated and she died on January 10, 1988. To our knowledge, there have been no prior reports of group B streptococcal suppurative arthritis complicating RA in Japan.
...
PMID:[Case report: suppurative arthritis due to group B Streptococcus in a patient with rheumatoid arthritis]. 831 3
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>